Procter & Gamble’s (PG) Outperform Rating Reaffirmed at Royal Bank Of Canada

Procter & Gamble (NYSE:PG – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at Royal Bank Of Canada in a report issued on Tuesday, Benzinga reports. They presently have a $166.00 price objective on the stock. Royal Bank Of Canada‘s price objective would suggest a potential upside of 2.97% from the stock’s current price.

Other research analysts have also issued research reports about the stock. Sanford C. Bernstein restated a “market perform” rating and issued a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. HSBC reissued a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a report on Thursday, July 30th. UBS Group reissued a “buy” rating on shares of Procter & Gamble in a report on Friday, October 16th. Barclays increased their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Finally, BMO Capital Markets increased their target price on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a report on Monday, June 29th. Fifteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $168.90.

Read Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Trading Down 2.6%

Shares of PG traded down $4.38 during mid-day trading on Tuesday, hitting $161.21. The company had a trading volume of 10,329,913 shares, compared to its average volume of 9,767,334. The business’s 50-day simple moving average is $148.41 and its 200-day simple moving average is $147.09. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The stock has a market cap of $374.43 billion, a PE ratio of 24.35, a P/E/G ratio of 3.90 and a beta of 0.39.

Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. During the same period last year, the company earned $1.99 earnings per share. The company’s quarterly revenue was up 4.0% on a year-over-year basis. Sell-side analysts forecast that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In other news, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the sale, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at approximately $9,536,920.12. This represents a 5.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the company’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the sale, the insider directly owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock worth $2,189,970 over the last ninety days. Insiders own 0.23% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of institutional investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $27,862,105,000. State Street Corp lifted its stake in shares of Procter & Gamble by 1.0% in the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after acquiring an additional 965,461 shares during the period. Bank of America Corp DE acquired a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $2,281,505,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock valued at $1,704,182,000 after purchasing an additional 300,280 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
  • Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
  • Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
  • Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
  • Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

About Procter & Gamble

(Get Free Report)

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Further Reading

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.